[en] BACKGROUND AND PURPOSE: To evaluate on 201 locally advanced prostatic cancers prospectively treated in a phase II trial, the efficacy of a combination of external beam radiotherapy (39.6 Gy) and (192)Ir low dose rate brachytherapy (Bt) (40-45 Gy). PATIENTS AND METHODS: Sixty-four patients were included in the intermediate prognosis group with only one of the following adverse factors (PSA > 10 ng/ml, Gleason score > or = 7 or clinical stage > or =T2b) and 137 in the unfavourable group when at least two of these factors were present. RESULTS: The actuarial 4 years biochemical no evidence of disease is 82.8% for the entire population. It is, respectively, 97 and 76% in the intermediate and unfavourable prognosis groups (P < 0.0001). Grade > or =3 late urinary complications occurred in 13 patients (6.5%). Eight patients (4%) presented late grade 2 rectal complications but no grades 3-5 was observed. CONCLUSIONS: Even if an alpha/beta of 1.5-3 Gy theoretically favours the use of a high dose rate mode of irradiation, the early results presented here are as good as those reported for similar groups of patients with high dose rate treatments. Late toxicity is identical but our urinary toxicity is within the less favourable and rectal toxicity within the most favourable results. We can postulate that while inducing very high hyperdosage regions (V150) mainly focused on the peripheral zone, most of the Bt techniques consist of a more ablative treatment. Many of the radiobiological studies on Bt did not in fact take into account the heterogeneity of irradiation inside the CTV. This study highlights the need to explore pulsed dose rate therapies, permanent implant and new available radioisotopes such as (169)Ytterbium that will offer the safety of low and lower dose rates. The actual late toxicity of the different Bt techniques is not yet inexistent indeed.
Disciplines :
Oncology Radiology, nuclear medicine & imaging
Author, co-author :
Nickers, Philippe ; Université de Liège - ULiège > Département des sciences cliniques
Coppens, Luc ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
De Leval, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Urologie
Jansen, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
Deneufbourg, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Radiothérapie
Language :
English
Title :
192ir Low Dose Rate Brachytherapy for Boosting Locally Advanced Prostate Cancers after External Beam Radiotherapy: A Phase Ii Trial
Alternative titles :
[fr] Brachythérapie de la prostate à base dose à l'iridium 192
Brachman D.G., Thomas T., Hilbe J., and Beyer D. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. Int J Radiat Oncol Biol Phys 48 (2000) 111-117
Consensus statement. Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
Cox D.R. Regression m models and life-tables. J R Stat Soc B 34 (1972) 187-220
Dale R.G. The use of small fraction numbers in high dose-rate gynaecological afterloading: some radiobiological considerations. Br J Radiol 63 (1990) 290-294
D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 280 (1998) 969-974
Damore S.J., Syed A.M., Puthawala A.A., and Sharma A. Needle displacement during HDR brachytherapy in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1205-1211
Demanes D.J., Rodriguez R.R., and Altieri G.A. High dose rate brachytherapy: the California endocurietherapy(CET) method. Radiother Oncol 57 (2000) 289-296
Dutreix A., and Marinello G. The Paris system. In: Pierquin B., Wilson J.F., and Chassagne D. (Eds). Modern brachytherapy (1987), Masson Publishing, Paris 25-42
Fowler J.F., and Van Limbergen E.F.M. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 37 (1997) 877-883
Galalae R.M., Kovacs G., Schultze J., et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 81-90
Galalae R.M., Martinez A., Mate T., et al. Long-term outcome by risk factors using conformal high dose rate (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1048-1055
Gelblum D.Y., Potters L., Ashley R., Waldbaum R., Wang X.H., and Leibel S. Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45 (1999) 59-67
Gelblum D.Y., and Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 119-124
Hoskin P., Bownes P., Ostler P., Walker K., and Bryant L. High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 68 (2003) 285-288
ICRU REPORT 38. Dose and volume specification for reporting intracavitary therapy in gynecology; 1985.
Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
King C.R., DiPetrillo T.A., and Wazer D.E. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT and brachytherapy from radiobiologic models. Int J Radiat Oncol Biol Phys 46 (2000) 165-172
Kovacs G., Potter R., Loch T., et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74 (2005) 137-148
Lee W.R., Moughan J., Owen J.B., and Zelefsky M.J. The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United States. Cancer 98 (2003) 1987-1994
Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
Martinez A., Edmundson G.K., Cox R.S., Gunderson L.L., and Howes A.E. Combination of external beam irradiation and multiple-site perineal applicator for treatment of locally advanced or recurrent prostatic, anorectal and gynaecologic malignancies. Int J Radiat Oncol Biol Phys 11 (1985) 391-398
Martinez A.A., Gustafson G., Gonzalez J., et al. Dose escalation using conformal high dose rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 316-327
Mate T.P., Gottesman J.E., Hatton J., Cribble M., and Van Hollebeke L. High dose rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 41 (1998) 525-533
Merrick G.S., Butler W.M., Galbreath R.W., and Lief J.H. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer. Int J Radiat Oncol Biol Phys 51 (2001) 41-48
Nickers P., Coppens L., Beauduin M., Darimont M., de Leval J., and Deneufbourg J.M. Feasibility study combining low dose rate 192 Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma. Radiother Oncol 55 (2000) 41-47
Nickers P., Lenaerts E., Thissen B., and Deneufbourg J.M. Does inverse planning applied to Iridium 192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system ?. Radiother Oncol 74 (2005) 131-136
Nickers P., Thissen B., Jansen N., and Deneufbourg J.M. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view. Radiother Oncol 78 (2006) 47-52
Niemierko A. Reporting and analysing dose distributions: a concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
Pickett B.P., Ten Haken R.K., Kurhanewicz J., et al. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 59 (2004) 665-673
Pieters B., Blank L., D'Olieslager G., van der Grient H., Koedoorder C., and de Reijke T. Minimal displacement of self-anchoring brachytherapy catheters in temporary prostate implants. Radiother Oncol 71 (2004) 119
Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomizezd trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
Puthawala A.A., Nisar Syed A.M., Tansey L.A., Shanberg A., Austin P.A., and McNamara C.S. Temporary iridium-192 implant in the management of carcinoma of the prostate: an analysis of treatment results and complications in the first one hundred patients. Endocurie Hypertherm Oncol 1 (1985) 25-34
Roach M., Lu J., Pilepich M.V., et al. Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials. Int J Radiat Oncol Biol Phys 47 (2000) 617-627
Sohayda C., Kupelian P.A., and Levin H.S. Extent of extracapsular extension in localized prostate cancer. Urology 55 (2000) 382-386
Sylvester J.E., Blasko J.C., Grimm P.D., Meier R., and Malmgren J.A. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. Int J Radiat Oncol Biol Phys 57 (2003) 944-952
Wang J.Z., Li X.A., Yu C.X., and DiBiase S.J. The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us ?. Int J Radiat Oncol Biol Phys 57 (2003) 1101-1108
Wang J.Z., and Li X.A. Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. Med Phys 30 (2003) 34-40
Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
Zelefsky M.J., Fuks Z., Hunt M., et al. High dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53 (2002) 1111-1116